NCT04881825: An ongoing trial by Zealand Pharma
This trial is ongoing. It must report results 4 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04881825 |
|---|---|
| Title | A 104-Week, Multicenter, Single-Arm, Long-Term, Phase 3 Extension Trial Investigating the Safety and Efficacy of Glepaglutide in Adult Patients With Short Bowel Syndrome (SBS) Completing the EASE SBS 2 Trial |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 16, 2021 |
| Completion date | April 30, 2025 |
| Required reporting date | April 30, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |